Download PDF
CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
DOI: 10.1055/s-0044-1788604
Case Report

Intracranial Solitary Fibrous Tumor with Concurrent Meningioma: Case Report and Review of the Literature

Tumor fibroso solitário intracraniano com meningioma concorrente: Relato de caso e revisão da literatura
Joaquin Vega Gonzales-Portillo 
1   Universidad Peruana de Ciencias Aplicadas, Lima, Perú
,
Marco Gonzales-Portillo Showing
2   Department of Neurosurgery, Instituto de Neurociencias de Lima, School of Medicine, Universidad Peruana Cayetano Heredia, Clínica San Felipe, Lima, Perú
,
Luis A. Huamán Tanta
3   Division of Neurosurgery, Hospital Nacional Dos de Mayo, Lima, Perú
,
Sandro Casavilca Zambrano
4   Management Unit of the National Tumor Bank, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction The present study describes a case of an intracranial solitary fibrous tumor (iSFT) concurrent with meningioma in different anatomical regions.

Case Description A female patient, 64-years-old, presented with an 18-month history of progressive vision impairment in the right eye and no other neurological symptoms. The magnetic resonance imaging (MRI) revealed two solid and expansive lesions: one with right interhemispheric occipital location and dependent on the falx cerebri, and another located in the anterior skull base. We opted for a right frontotemporal craniotomy for the first tumor, and a right occipital craniotomy, 41-days later, for the second one, showing no postoperative complications. Histological and immunohistochemical findings confirmed the diagnosis of a grade-I fibrous meningioma and a grade-III SFT. After 9 months of follow-up, the patient showed vision improvement and no signs of neurological compromise or tumor recurrence in the last MRI.

Conclusions The present study describes the first reported case of a patient with an intracranial SFT associated with a meningioma in different anatomical locations. The involved pathogenesis and evolution of both coexisting tumors are still unknown, which highlights the need for more case reports on them.

Resumo

Introdução O presente estudo descreve um caso de tumor fibroso solitário intracraniano (TFSi) concomitante a meningioma em diferentes regiões anatômicas.

Descrição do Caso Paciente do sexo feminino, com 64 anos de idade, apresentava história de comprometimento visual progressivo no olho direito há 18 meses e sem outros sintomas neurológicos. A ressonância magnética revelou duas lesões sólidas e expansivas: uma com localização occipital interhemisférica direita e dependente da foice cerebral, e outra localizada na base anterior do crânio. Optamos por craniotomia frontotemporal direita para o primeiro tumor e craniotomia occipital direita 41 dias depois para o segundo, sem complicações pós-operatórias. Os achados histológicos e imunohistoquímicos confirmaram o diagnóstico de meningioma fibroso grau I e TFS III. Após 9 meses de acompanhamento, a paciente apresentou melhora visual e não apresentou sinais de comprometimento neurológico nem de recidiva na última ressonância magnética.

Conclusões O presente estudo descreve o primeiro caso relatado de um paciente com TFS intracraniano associado a um meningioma em diferentes localizações anatômicas. A patogênese e a evolução envolvidas nos dois tumores coexistentes permanecem obscuras, o que destaca a necessidade de mais relatos de casos sobre eles.

Keywords

intracranial solitary fibrous tumor - meningioma - mesenchymal neoplasm - case report - surgical treatment

Palavras-chave

tumor fibroso solitário intracraniano - meningioma - neoplasia mesenquimal - relato de caso - tratamento cirúrgico


Publication History

Received: 17 February 2024

Accepted: 16 May 2024

Article published online:
26 July 2024

© 2024. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Wang Y, Zhang J, Liu Q, Liu F, Zhu X, Zhang J. Solitary fibrous tumor of the pineal region with delayed ectopic intracranial metastasis: A case report and review of the literature. Medicine (Baltimore) 2019; 98 (21) e15737
    CrossrefPubMedGoogle Scholar
  • 2 Apra C, El Arbi A, Montero AS, Parker F, Knafo S. Spinal solitary fibrous tumors: An original multicenter series and systematic review of presentation, management, and prognosis. Cancers (Basel) 2022; 14 (12) 2839
    CrossrefPubMedGoogle Scholar
  • 3 Bisceglia M, Galliani C, Giannatempo G. et al. Solitary fibrous tumor of the central nervous system: A 15 year literature survey of 220 cases (August 1996 - July 2011). Adv Anat Pathol 2011; 18: 356392
    CrossrefPubMedGoogle Scholar
  • 4 Wang L, Yu J, Shu D, Huang B, Wang Y, Zhang L. Primary endodermal hemangiopericytoma/solitary fibrous tumor of the cervical spine: a case report and literature review. BMC Surg 2021; 21 (01) 405
    CrossrefPubMedGoogle Scholar
  • 5 Hu SW, Tsai KB, Yang SF, Lee KS, Chai CY. Unusual solitary fibrous tumors in the central nervous system: a report of two cases. Kaohsiung J Med Sci 2005; 21 (04) 179-184
    CrossrefPubMedGoogle Scholar
  • 6 Central Nervous System Tumours. WHO Classification of 5th Edition, Volume 6. Lyon: International Agency for Research on Cancer; 2021
    Google Scholar
  • 7 Stout AP, Murray MR. Hemangiopericytoma a vascular tumor featuring Zimmermann's Pericytes. Ann Surg 1942; 116 (01) 26-33
    CrossrefPubMedGoogle Scholar
  • 8 Allen AJ, Labella DA, Richardson KM, Sheehan JP, Kersh CR. Recurrent solitary fibrous tumor (Intracranial Hemangiopericytoma) treated with a novel combined-modality radiosurgery technique: A case report and review of the literature. Front Oncol 2022; 12 (907324): 907324
    CrossrefPubMedGoogle Scholar
  • 9 Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985; 35 (02) 219-226
    CrossrefPubMedGoogle Scholar
  • 10 Aljohani HT, Chaussemy D, Proust F, Chibbaro S. Intracranial solitary fibrous tumor/hemangiopericytoma: Report of two cases and literature review. Int J Health Sci (Qassim) 2017; 11 (03) 69-70
    PubMedGoogle Scholar
  • 11 Kinslow CJ, Bruce SS, Rae AI. et al. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study. J Neurooncol 2018; 138 (01) 173-182
    CrossrefPubMedGoogle Scholar
  • 12 Yamashita D, Suehiro S, Kohno S. et al. Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis. Neurosurg Rev 2021; 44 (03) 1591-1600 DOI: 10.1007/s10143-020-01348-6.
    CrossrefPubMedGoogle Scholar
  • 13 Li Q, Deng W, Sun P. Effect of Different Treatments for Intracranial Solitary Fibrous Tumors: Retrospective Analysis of 31 Patients. World Neurosurg 2022; 166: e60-e69 DOI: 10.1016/j.wneu.2022.06.089.
    CrossrefPubMedGoogle Scholar
  • 14 Liu N, Song SY, Jiang JB, Wang TJ, Yan CX. The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis. Medicine (Baltimore) 2020; 99 (09) e18644
    CrossrefPubMedGoogle Scholar
  • 15 Chmielecki J, Crago AM, Rosenberg M. et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013; 45 (02) 131-132 DOI: 10.1038/ng.2522.
    CrossrefPubMedGoogle Scholar
  • 16 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131 (06) 803-820 DOI: 10.1007/s00401-016-1545-1.
    CrossrefPubMedGoogle Scholar
  • 17 Robinson DR, Wu YM, Kalyana-Sundaram S. et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013; 45 (02) 180-185 DOI: 10.1038/ng.2509.
    CrossrefPubMedGoogle Scholar
  • 18 Schweizer L, Koelsche C, Sahm F. et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 2013; 125 (05) 651-658 DOI: 10.1007/s00401-013-1117-6.
    CrossrefPubMedGoogle Scholar
  • 19 Sardaro A, Mammucci P, Pisani AR. et al. Intracranial solitary fibrous tumor: A new challenge for PET Radiopharmaceuticals. J Clin Med 2022; 11 (16) 4746
    CrossrefPubMedGoogle Scholar
  • 20 WHO Classification of Tumours. Soft Tissue and Bone Tumours. 5th ed. Volume 3.. IARC Press; Lyon, France: 2020
    Google Scholar
  • 21 Kallen ME, Hornick JL. The 2020 WHO Classification: What's new in soft tissue tumor pathology?. Am J Surg Pathol 2021; 45 (01) e1-e23
    CrossrefPubMedGoogle Scholar
  • 22 Ostrom QT, Cioffi G, Gittleman H. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-oncol 2019; 21 (5, Suppl 5) v1-v100
    CrossrefPubMedGoogle Scholar
  • 23 Ashizawa K, Ogura K, Nagase S. et al. A collision tumor of solitary fibrous tumor/hemangiopericytoma and meningioma: A case report with literature review. Pathol Int 2021; 71 (10) 697-706
    CrossrefPubMedGoogle Scholar
  • 24 Binello E, Bederson JB, Kleinman GM. Hemangiopericytoma: collision with meningioma and recurrence. Neurol Sci 2010; 31 (05) 625-630
    CrossrefPubMedGoogle Scholar
  • 25 Yan H, Luo K, Liu B, Kang J. A solitary fibrous tumor with concurrent meningioma at the same site: A case report and review of the literature. Oncol Lett 2016; 11 (06) 3655-3659 DOI: 10.3892/ol.2016.4486.
    CrossrefPubMedGoogle Scholar
  • 26 Davis GA, Fabinyi GC, Kalnins RM, Brazenor GA, Rogers MA. Concurrent adjacent meningioma and astrocytoma: a report of three cases and review of the literature. Neurosurgery 1995; 36 (03) 599-604 , discussion 604–605
    PubMedGoogle Scholar
  • 27 Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines 2021; 9 (03) 319
    CrossrefPubMedGoogle Scholar
  • 28 Spallone A, Santoro A, Palatinsky E, Giunta F. Intracranial meningiomas associated with glial tumours: a review based on 54 selected literature cases from the literature and 3 additional personal cases. Acta Neurochir (Wien) 1991; 110 (3-4): 133-139
    CrossrefPubMedGoogle Scholar
  • 29 Russell DS, Rubinstein LJ. Pathology of Tumors of the Nervous System. 5th edition. Edward Arnold, London 1989
    Google Scholar
  • 30 Myerson PG. Multiple tumors of the brain of diverse origin. J Neuropathol Exp Neurol 1942; 1: 406415
    CrossrefPubMedGoogle Scholar
  • 31 Suzuki K, Momota H, Tonooka A. et al. Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature. J Neurooncol 2010; 99 (01) 147-153
    CrossrefPubMedGoogle Scholar
  • 32 Andrioli GC, Zuccarello M, Scanarini M, d'Avella D. Concurrent primary intracranial tumours of different histogenesis. Acta Neuropathol Suppl 1981; 7: 111-115
    CrossrefPubMedGoogle Scholar
  • 33 Corniola MV, Meling TR. Management of Recurrent Meningiomas: State of the Art and Perspectives. Cancers (Basel) 2022; 14 (16) 3995 DOI: 10.3390/cancers14163995.
    CrossrefPubMedGoogle Scholar
  • 34 Tian W, Liu J, Zhao K. et al. Analysis of prognostic factors of World Health Organization grade III meningiomas. Front Oncol 2020; 10: 593073
    CrossrefPubMedGoogle Scholar
  • 35 Berghoff AS, Kresl P, Bienkowski M. et al. Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma. Clin Neuropathol 2017; 36 (02) 56-59 DOI: 10.5414/NP300993.
    CrossrefPubMedGoogle Scholar
  • 36 Demicco EG, Harms PW, Patel RM. et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 2015; 143 (05) 672-682
    CrossrefPubMedGoogle Scholar
  • 37 Doyle LA, Vivero M, Fletcher CDM, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 2014; 27 (03) 390-395
    CrossrefPubMedGoogle Scholar
  • 38 Koelsche C, Schweizer L, Renner M. et al. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology 2014; 65 (05) 613-622
    CrossrefPubMedGoogle Scholar
  • 39 Sahoo N, Mohapatra D, Panigrahi S, Lenka A, Das P, Mohapatra SS. Intracranial solitary fibrous tumor/hemangiopericytoma: A clinico-radiological poorly recognized entity- An institutional experience. Turk Neurosurg 2020; DOI: 10.5137/1019-5149.JTN.31204-20.2.
    CrossrefPubMedGoogle Scholar
  • 40 Yoshida A, Tsuta K, Ohno M. et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014; 38 (04) 552-559
    CrossrefPubMedGoogle Scholar
  • 41 Dermawan JK, Rubin BP, Kilpatrick SE. et al. CD34-negative Solitary Fibrous Tumor: A Clinicopathologic Study of 25 Cases and Comparison With Their CD34-positive Counterparts. Am J Surg Pathol 2021; 45 (12) 1616-1625 DOI: 10.1097/ PAS.0000000000001717.
    CrossrefPubMedGoogle Scholar
  • 42 de Bernardi A, Dufresne A, Mishellany F, Blay JY, Ray-Coquard I, Brahmi M. Novel therapeutic options for solitary fibrous tumor: Antiangiogenic therapy and beyond. Cancers (Basel) 2022; 14 (04) 1064
    CrossrefPubMedGoogle Scholar
  • 43 Dilani L, Valerie AW, Ian AC. Soft tissue and bone tumours. In WHO classification of tumours. 5th ed.. Antonescu, C.R., Bridge, J.A., Cunha, I.W., Dei Tos, A.P., Fletcher, C.D., Folpe, A.L., Goldblum, J.R., Hornick, J.L., Miettinen, M., Oda, Y., Eds.; International Agency for Research on Cancer; Lyon, France: 104–108 2020
    Google Scholar
  • 44 Cohen-Inbar O. Nervous System Hemangiopericytoma. Can J Neurol Sci 2020; 47 (01) 18-29 DOI: 10.1017/cjn.2019.311.
    CrossrefPubMedGoogle Scholar
  • 45 Enzinger FM, Smith BH. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol 1976; 7 (01) 61-82
    PubMedGoogle Scholar
  • 46 Sibtain NA, Butt S, Connor SE. Imaging features of central nervous system haemangiopericytomas. Eur Radiol 2007; 17 (07) 1685-1693
    CrossrefPubMedGoogle Scholar
  • 47 Zhou JL, Liu JL, Zhang J, Zhang M. Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings. Eur J Radiol 2012; 81 (11) 3504-3510
    CrossrefPubMedGoogle Scholar
  • 48 Liu G, Chen ZY, Ma L, Lou X, Li SJ, Wang YL. Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimum ADC values. J Magn Reson Imaging 2013; 38 (05) 1146-1151
    CrossrefPubMedGoogle Scholar
  • 49 Ciliberti MP, D'Agostino R, Gabrieli L, Nikolaou A, Sardaro A. The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor. Oncol Rev 2018; 12 (02) 354
    PubMedGoogle Scholar
  • 50 Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol 2018; 14 (21) 2161-2177 DOI: 10.2217/fon-2018-0006.
    CrossrefPubMedGoogle Scholar
  • 51 Hanna Jr C, Willman M, Cole D. et al. Review of meningioma diagnosis and management. Egypt J Neurosurg 2023; 38 (01) 16 Epub 2023 Apr 17 DOI: 10.1186/s41984-023-00195-z.
    CrossrefPubMedGoogle Scholar